AMETEK

US · AME #410 by market cap Listed 1970

248.62 -5.10 -2.01%

Live - 5344 symbols - heartbeat 50s ago · 2026-10-08 04:01

Pre-market 248.62 0.00%

After-hours 248.62 0.00%

Overnight 249.18 +0.23%

Market cap: 57.00B
P/E (TTM): 36.35
P/B: 5.06
EPS: 6.40
Div yield: 0.52%
52W pos: 85%

Reader sentiment Are you bullish or bearish on AME?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 8.22, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +6.63% YoY

Margins

Gross margin: 36.04%
Operating margin: 25.81%
Net margin: 20.00%

Key ratios & quality

Enterprise value: 58.89B
PEG ratio: 4.29
Altman Z-Score: 8.22

PEG uses trailing P/E against the 3-year net income growth rate (8.48%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	4.85B	5.16B	4.54B	5.55B	6.15B	6.60B	6.94B	7.40B
Gross profit	1.66B	1.79B	1.54B	1.91B	2.15B	2.38B	2.48B	2.67B
Selling & admin expenses	584.02M	610.28M	515.63M	603.94M	644.58M	677.01M	696.91M	757.12M
Research & development	--	--	--	--	--	--	--	--
Operating profit	1.08B	1.18B	1.03B	1.31B	1.50B	1.71B	1.78B	1.91B
Pretax profit	987.75M	1.07B	1.08B	1.22B	1.43B	1.61B	1.66B	1.80B
Tax	209.81M	208.45M	209.87M	233.12M	269.15M	293.22M	285.42M	318.20M
Net profit	777.93M	861.30M	872.44M	990.05M	1.16B	1.31B	1.38B	1.48B
Basic EPS	3	4	4	4	5	6	6	6
Diluted EPS	3.34	3.75	3.77	4.25	5.01	5.67	5.93	6.40

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	1.73B	1.78B	1.89B	2.00B	1.93B	2.04B
Gross profit	625.00M	635.89M	686.14M	720.41M	717.56M	735.04M
Selling & admin expenses	170.17M	174.26M	197.76M	214.93M	202.62M	206.85M
Research & development	--	--	--	--	--	--
Operating profit	454.83M	461.63M	488.38M	505.48M	514.94M	528.19M
Pretax profit	434.22M	442.17M	447.97M	473.98M	492.98M	492.37M
Tax	82.46M	83.80M	76.55M	75.38M	93.62M	85.48M
Net profit	351.76M	358.37M	371.42M	398.60M	399.36M	406.90M
Basic EPS	2	2	2	2	2	2
Diluted EPS	1.52	1.55	1.60	1.73	1.74	1.77

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	1.84B	2.03B	2.52B	2.13B	2.53B	2.82B	2.60B	3.02B
Cash & ST investments	353.98M	393.03M	1.21B	346.77M	345.39M	409.80M	374.00M	457.95M
Inventory	624.74M	624.57M	559.17M	769.18M	1.04B	1.13B	1.02B	1.11B
Total assets	8.66B	9.84B	10.36B	11.90B	12.43B	15.02B	14.63B	16.07B
Total current liabilities	1.26B	1.43B	1.08B	1.56B	1.56B	2.88B	2.10B	2.84B
Short-term debt	358.88M	540.47M	177.23M	362.45M	272.45M	1.48B	709.08M	1.27B
Long-term debt	2.27B	2.27B	2.28B	2.23B	2.16B	1.90B	1.43B	1.07B
Total liabilities	4,420,366,000.00	4,729,067,000.00	4,408,137,000.00	5,026,303,000.00	4,954,608,000.00	6,293,342,000.00	4,975,865,000.00	5,438,757,000.00
Total equity	4.24B	5.12B	5.95B	6.87B	7.48B	8.73B	9.66B	10.63B
Retained earnings	5.65B	6.39B	7.09B	7.90B	8.86B	9.94B	11.06B	12.25B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	2.76B	3.05B	3.06B	3.02B	3.14B	3.23B
Cash & ST investments	399.00M	619.71M	439.24M	457.95M	481.25M	495.45M
Inventory	1.07B	1.11B	1.15B	1.11B	1.14B	1.20B
Total assets	14.88B	15.27B	16.18B	16.07B	16.31B	16.59B
Total current liabilities	1.96B	1.87B	2.65B	2.84B	2.76B	2.66B
Short-term debt	471.52M	407.65M	1.04B	1.27B	1.11B	980.63M
Long-term debt	1.46B	1.53B	1.43B	1.07B	1.06B	1.06B
Total liabilities	4,907,150,000.00	4,877,874,000.00	5,655,381,000.00	5,438,757,000.00	5,390,238,000.00	5,333,950,000.00
Total equity	9.97B	10.39B	10.53B	10.63B	10.92B	11.26B
Retained earnings	11.34B	11.62B	11.92B	12.25B	12.57B	12.90B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	925.52M	1.11B	1.28B	1.16B	1.15B	1.74B	1.83B	1.80B
Depreciation & amortization	199.49M	234.04M	255.28M	292.11M	319.43M	337.64M	382.93M	422.80M
Free cash flow	843.44M	1.01B	1.21B	1.05B	1.01B	1.60B	1.70B	1.67B
Dividends paid	-128.91M	-127.50M	-165.04M	-184.60M	-202.17M	-230.33M	-258.78M	-285.35M
Stock buybacks / issuance	-367.68M	-11.92M	-4.69M	-14.71M	-332.82M	-7.77M	-212.03M	-434.05M
Ending cash balance	353.98M	393.03M	1.21B	346.77M	345.39M	409.80M	374.00M	457.95M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	417.55M	359.09M	440.87M	584.26M	451.52M	483.69M
Depreciation & amortization	106.37M	107.70M	103.08M	105.66M	105.49M	105.93M
Free cash flow	394.48M	329.82M	419.95M	527.27M	426.05M	451.68M
Dividends paid	-71.46M	-71.51M	-71.41M	-70.98M	-77.80M	-77.86M
Stock buybacks / issuance	-18.01M	-111.00K	-145.50M	-270.43M	-27.94M	-165.00K
Ending cash balance	399.00M	619.71M	439.24M	457.95M	481.25M	495.45M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	18.81	18.41	15.77	15.44	16.16	16.21	14.97	14.59
ROA %	9.45	9.31	8.64	8.90	9.53	9.57	9.28	9.64
ROIC %	12.89	12.60	11.53	11.81	12.59	12.47	12.30	12.49
5-year avg ROE %	17.96	17.97	17.49	17.43	16.92	16.40	15.71	15.48
EBIT margin %	22.08	22.45	25.73	23.50	24.58	25.59	25.56	25.40
FCF / sales %	17.41	19.62	26.58	18.93	16.43	24.24	24.52	22.58
Current ratio	1.46	1.42	2.34	1.36	1.62	0.98	1.24	1.06
Quick ratio	0.86	0.80	1.68	0.75	0.81	0.49	0.63	0.55
Debt / assets	30.39	28.56	23.74	22.87	19.56	22.46	14.59	14.59
LT debt / equity	53.60	44.40	38.35	34.32	28.88	21.71	14.76	10.11
Interest coverage	13.02	13.09	13.58	16.22	18.17	20.64	15.71	23.13
Revenue CAGR (3Y) %	6.83	10.34	1.83	4.60	6.04	13.26	7.76	6.36
Net income CAGR (3Y) %	9.60	18.92	8.58	8.37	10.42	14.60	11.60	8.48
FCF CAGR (3Y) %	11.81	13.43	16.76	7.57	-0.06	9.84	17.47	18.27

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	14.96	14.64	14.63	14.59	14.63	14.56
ROA %	9.53	9.56	9.49	9.64	9.80	9.89
ROIC %	12.58	12.43	12.34	12.49	12.77	12.92
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	26.11	26.11	25.81	25.40	25.54	25.48
FCF / sales %	24.70	24.12	22.93	22.58	22.42	23.21
Current ratio	1.41	1.63	1.16	1.06	1.14	1.21
Quick ratio	0.71	0.88	0.59	0.55	0.59	0.63
Debt / assets	12.98	12.72	15.23	14.59	13.35	12.27
LT debt / equity	14.64	14.77	13.55	10.11	9.73	9.37
Interest coverage	18.73	21.97	23.01	23.13	23.33	20.78
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Lead segment, long tail

Electronic Instruments Group (EIG) is the largest reported line at 64.62% of revenue, across 2 reported segments.
Electromechanical (EMG) follows at 35.38%, so the top line still matters most but isn’t the whole story.

Revenue breakdown most recent period

Business

Electronic Instruments Group (EIG)64.62%

Electromechanical (EMG)35.38%

Quote time 2026-10-08 04:01:02 · For reference only, not investment advice and not tailored to your situation.